Atlas Trials

Efficacy and Tolerability of a New Oral Extended-Release Formulation Containing Parnaparin Sodium, Administered Add-on Therapy

Clinical trial NCT00867438 · COMPLETED

Trial details

NCT number
NCT00867438
Sponsor
Cosmo Technologies Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2007-01-01
Primary completion
2007-11-01
Enrollment
133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.